Shorten Device Payment Timeframe, Develop Criteria, U.S. Presses Japan
This article was originally published in The Gray Sheet
Executive Summary
Japan's current preoccupation with orthopedic industry pricing practices is distracting the government from pursuing approval and reimbursement reforms for breakthrough devices, according to AdvaMed.
You may also be interested in...
AdvaMed chairman-elect Collins
Medtronic Chairman & CEO Art Collins will be named incoming AdvaMed chairman for 2004 and 2005 at the device trade group's annual meeting March 19-22 in Aventura, Fla. Collins previously testified on behalf of AdvaMed to the House Ways & Means/Trade Subcommittee on expanding Japanese market opportunities (1"The Gray Sheet" Oct. 29, 2001, p. 9)...
AdvaMed chairman-elect Collins
Medtronic Chairman & CEO Art Collins will be named incoming AdvaMed chairman for 2004 and 2005 at the device trade group's annual meeting March 19-22 in Aventura, Fla. Collins previously testified on behalf of AdvaMed to the House Ways & Means/Trade Subcommittee on expanding Japanese market opportunities (1"The Gray Sheet" Oct. 29, 2001, p. 9)...
Established Firms Have Most To Gain From Japanese Device Revisions
Members of the Japanese Ministry of Health, Labor and Welfare are meeting with notified bodies (NBs) in the UK to better understand how elements of the European regulatory system would apply in Japan